LONDON--(BUSINESS WIRE)--Agalimmune Ltd, a biopharmaceutical company focused on the development of a pipeline of innovative immunotherapies for the personalised treatment of cancer, announced today it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results